FULLER & THALER ASSET MANAGEMENT, INC. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 72 filers reported holding ANTARES PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FULLER & THALER ASSET MANAGEMENT, INC. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2020$2,043,000
+40.3%
511,999
-5.0%
0.02%
+5.6%
Q3 2020$1,456,000
-7.0%
539,099
-5.3%
0.02%
-14.3%
Q2 2020$1,565,000
+13.7%
569,069
-2.5%
0.02%
-8.7%
Q1 2020$1,377,000
-45.0%
583,659
+9.6%
0.02%
-17.9%
Q4 2019$2,502,000
+41.0%
532,405
+0.3%
0.03%
+33.3%
Q3 2019$1,775,000
+1.7%
530,7050.0%0.02%
+5.0%
Q2 2019$1,746,000
+8.0%
530,705
-0.5%
0.02%0.0%
Q1 2019$1,616,000
+13.0%
533,405
+1.5%
0.02%
-4.8%
Q4 2018$1,430,000
-17.7%
525,765
+1.6%
0.02%
+16.7%
Q3 2018$1,738,000
+30.2%
517,3000.0%0.02%
+28.6%
Q2 2018$1,335,000
+17.3%
517,3000.0%0.01%
+7.7%
Q1 2018$1,138,000
+3.3%
517,300
-6.6%
0.01%0.0%
Q4 2017$1,102,000
-53.4%
554,000
-24.2%
0.01%
-55.2%
Q3 2017$2,367,000
+0.2%
730,600
-0.4%
0.03%
-6.5%
Q2 2017$2,363,000
+13.0%
733,800
-0.4%
0.03%
+6.9%
Q1 2017$2,091,000
+21.9%
736,4000.0%0.03%
+11.5%
Q4 2016$1,716,000
+38.7%
736,4000.0%0.03%
+30.0%
Q3 2016$1,237,000
+55.2%
736,400
-3.0%
0.02%
+42.9%
Q2 2016$797,000758,9000.01%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders